Can aromatase inhibitors lower the risk of breast cancer. Given the appreciable late recurrence rates in women with erpositive breast cancer following 5 years of adjuvant tamoxifen, the ma. Aromatase inhibitor endocrine therapy for breast cancer for more patient education information. Breast research unit, western general hospital, edinburgh, uk.
In general, aromatase inhibitors are only used to treat breast cancer in postmenopausal women. But youd like to avoid uncomfortable side effects that might lower your quality of life. Getting the best breast cancer treatment can feel like a balancing act. Pdf primarily, the role of the aromatase inhibitors has been investigated in postmenopausal women with breast cancer, although it is also now being. Aromatase inhibitors help reduce the amount of oestrogen made in the body. The potent and selective third generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were. Aromatase inhibitors represent an effective endocrine treatment for patients with hormone receptor positive breast cancer, both in early stage and in metastatic disease. It is involved in the conversion of androgens to estrogens.
Recommendations for prioritization, treatment and triage. But having a risk factor, or even many, does not mean that you are sure to get. Aromatase inhibitors in the treatment of breast cancer. Aromatase inhibitors for lowering breast cancer risk. But some studies of anastrozole and exemestane have also found that they can lower breast cancer risk in postmenopausal women who are at increased risk. Cardiotoxicity of aromatase inhibitors in breast cancer.
Pdf resistance to aromatase inhibitors in breast cancer. Nsais such as letrozole and anastrozole, on the other hand inhibit aromatase in a reversible manner by binding to the. As aromatase catalyzes the final and ratelimiting step in the biosynthesis of estrogen, inhibitors of this enzyme are effective targeted therapy for breast cancer. Use of an aromatase inhibitor as initial therapy or after treatment with tamoxifen is. Aromatase inhibitors tend to cause fewer serious side effects than tamoxifen, such as blood clots, stroke, and endometrial cancer.
Three aromatase inhibitors ais are now fda approved and have been shown to be more effective than the antiestrogen tamoxifen and are well tolerated. Pdf microsomal cytochrome p450 cyp 450 enzyme aromatase belongs to cyp 19 super family. Key words breast cancer, aromatase inhibitors, premenopausal women, tamoxifen, lhrh analog. Aromatase inhibitors are endocrine agents which have a different mode of action against breast tumors in postmeno pausal women from that of tamoxifen. Blocks the synthesis of estrogen lowers the estrogen level. Before the menopause, oestrogen is mainly produced in the ovaries. Role of aromatase inhibitors in the treatment of breast cancer. Estrogen is synthesized from testosterone by the enzyme aromatase this is why body builders use aromatase inhibitors. This comprehensive volume brings together the current. Used for post menopausal women who have er positive breast cancer. Aromatase inhibitor endocrine therapy for breast cancer.
Aromatase inhibitors are used to treat breast cancer in women. This is a pdf file of an unedited manuscript that has been accepted. Postmenopausal women with early stage and metastatic breast cancer are often treated with ais. Pdf role of aromatase inhibitors in the treatment of. Aromatase inhibitors as extended endocrine adjuvant therapy. Endocrine therapy is the cornerstone of treatment of the hormonesensitive subtype of breast cancer. Its efficacy as a firstline treatment in metastatic breast cancer has been demonstrated. These drugs act by suppression of the supply of endogenous estrogens in fat, liver, and muscle cells and in breast tumor tissue itself. Aromatase inhibitors ais treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. Aromatase, aromatase inhibitors, and breast cancer ncbi. However, some premenopausal women may take an aromatase inhibitor when combined with ovarian suppression. Pdf role of aromatase inhibitors in breast cancer researchgate. Aromatase inhibitors in the treatment of breast cancer endocrine.
218 514 382 1380 113 958 1404 489 1320 714 326 1208 468 451 644 653 964 1429 654 949 899 1060 314 917 469 391 1302 126 1218 700 411 1080 1376 826 527 355 786 533 609 592 1397 436 411 941